Solutions

Mission-driven science

A dedicated portfolio of impactful solutions that help prevent malaria and improve the lives of those most affected by the disease.

Vector Control

Core Products

Landcent’s Prevention Portfolio's core products are Insecticide-Treated Nets (ITNs) and antimalarials for children and pregnant women in endemic regions.

Neonet®

Insecticide-Treated Net
  • Dual Active Ingredient (AI) bed net designed to fight insecticide resistance; highly effective in killing mosquitoes transmitting malaria

Codispaq® & Lansipar®

Malaria Preventive Medication
  • Long-acting antimalarials for children and pregnant women in endemic regions
Active Ingredient (AI)

Discovery Project

Landcent is developing novel AIs to incorporate in its existing products and create new solutions, ensuring malaria prevention remains effective now and in the future

Funded by Landcent and the Gates Foundation, the Shanghai Institute of Organic Chemistry (SIOC) in China has, over the past two years, screened more than 230,000 natural compounds through the work of a team of 12 scientists, toxicology experts, and laboratory staff.

“(for the) enhancement of the grantee's reputation as an innovator company”.

Gates Foundation on why they backed Landcent

Accelerate Lasting Impact

Invest with Us

Landcent offers a unique, de-risked investment opportunity for impact-focused investors who want to advance the elimination of poverty-related diseases, starting with malaria. Together, we can help break the vicious cycle of poverty and disease for the world’s most vulnerable communities.

Sourcing as a Service

Sourcing for Impact

A significant part of Landcent's history has been to provide "Sourcing as a Service" for supplemental income. We reinvest these profits in research and development for our malaria products. In addition to sourcing high-quality laboratory consumables, diagnostic kits, and instruments, we also guarantee a resilient supply chain.

Read more

We work with